Functional neuroimaging with positron emission tomography

Epilepsia

Volumn 37, Issue 12, 1996, Pages 1141-1154

  Henry, Thomas R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epilepsy; Neuroimaging; Positron emission tomography

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE RECEPTOR;

ARTICLE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG RECEPTOR BINDING; EPILEPSY; HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR DENSITY;

EID: 0029835905     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1996.tb00546.x     Document Type: Article

References (124)

1. Fariello RG, Forchetti CM, Fisher RS. GABAergic function in relation to seizure phenomena. In: Fisher RS, Coyle JT, eds. Neurotransmitten and Epilepsy New York:Wiley-Liss 1991:77-94.
2. A receptor channels. Annu Rev Neurosci 1994;17:569-602.
3. Sivilotti L, Nistri A. GABA receptor mechanisms in the central nervous system. Prog Neurobiol 1991;36:35-92.
4. 11C]-labelled Ro 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomography. J Psychiatr Res 1985; 19:609-22.
5. 11C]RO 15-1788, a benzodiazepine antagonist, studied in human brain in vivo by positron tomography. Eur J Pharmacol 1985;110:247-51.
6. Frey KA, Holthoff VA, Koeppe RA, Jewett DM, Kilbourn MR, Kuhl DE. Parametric in vivo imaging of benzodiazepine receptor distribution in human brain. Ann Neurol 1991;30:663-72.
7. 11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cerebr Blood Flow Metab 1991; 11:735-44.
8. Rothstein JD, Garland W, Puia G, et al. Purification and characterization of naturally occurring benzodiazepine receptor ligands in rat and human brain. J Neurochem 1992;58:2102-15.
9. Henry TR, Frey KA, Sackellares JC, et al. In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology 1993c;43:1998-2006.
10. Savic I, Persson A, Roland P, Paulis S, Sedvall G, Widen L. In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet 1988; 8616:863-6.
11. 18F]FDG as PET markers of epileptic foci. J Neurol Neurosurg Psychiatry 1993;56:615-21.
12. 11C]flumazenil positron emission tomography visualizes frontal epileptogenic regions. Epilepsia 1995b;36:1225-32.
13. Burdette DE, Sakurai SY, Henry TR, et al. Temporal lobe central benzodiazepine binding in unilateral mesial temporal lobe epilepsy. Neurology 1995;45:934-41.
14. Johnson EW, de Lanerolle NC, Kim JH, et al. "Central" and "peripheral" benzodiazepine receptors: opposite changes in human epileptogenic tissue. Neurology 1992;42:811-5.
15. McDonald JW, Garofalo EA, Hood T, et al. Altered excitatory and inhibitory amino acid receptor binding in hippocampus of patients with temporal lobe epilepsy. Ann Neurol 1991;29:529-41.
16. 11C]Flumazenil positron emission tomography in children with intractable epilepsy. Epilepsia 1994:36(suppl): 525-6.
17. Savic I, Svanborg E, Thorell JO. Cortical benzodiazepine receptor changes are related to frequency of partial seizures: a positron emission tomography study. Epilepsia 1996;37:236-44.
18. 11C]flumazenil PET. Neurology 1996;46(Suppl):A123.
19. 11C]flumazenil PET agrees with multimodal localization of epileptogenesis in refractory complex partial seizures. Neurology 1992;42(Suppl 3):297-8.
20. Berkovic SF, Newton MR, Chiron C, Dulac O. Single photon emission tomography. In: Engel J Jr, ed. Surgical Treatment of the Epilepsies. 2nd ed. Raven Press: New York. 1993;233-43.
21. Theodore WH, Gaillard WD, Sato S, Kufta C, Leiderman D. Positron emission tomographic measurement of cerebral blood flow and temporal lobectomy. Ann Neurol 1994;36:241-4.
22. 11C]flumazenil and positron emission tomography. Epilepsia 1995b;36:113-21.
23. A receptor binding during absence seizures. Epilepsia 1995c;36:592-9.
24. Savic I, Pauli S, Thorell JO, Blomqvist G. In vivo demonstration of altered benzodiazepine receptor density in patients with generalised epilepsy. J Neurol Neurosurg Psychiatry 1994;57:797-804.
25. Dingledine R. Possible mechanisms of enkephalin action on hippocampal CA1 pyramidal neurons. J Neurosci 1981;1:1022-35.
26. Pfeiffer A, Pasi A, Mehraein P, Herz A. Opiate receptor binding sites in human brain. Brain Res 1982;248:87-96.
27. Snead OC, Simonato M. Opioid peptides and seizures. In: Fisher RS, Coyle JT, eds. Neurotransmitters and epilepsy New York-:Wiley-Liss 1991:181-200.
28. Engel J Jr. Neurochemical disturbances in epilepsy: relationship to behavior. In: Devinsky O, Theodore WH, eds. Epilepsy and Behavior New York:Wiley-Liss 1991:335-43.
29. 11C]-carfentanil binding to opiate receptors in humans measured by positron emission tomography. J Cereb Blood Flow Metab 1989;9:398-409.
30. 11C]diprenorphine cerebral kinetics in man acquired by PET using presaturation, pulse-chase and tracer-only protocols. J Neurosci Methods 1994;51:123-34.
31. 18F]cyclofoxy and positron emission tomography. J Cereb Blood Flow Metab 1993;13:24-42.
32. Frost JJ, Mayberg HS, Fisher RS, et al. Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy. Ann Neural 1988;23:231-7.
33. Mayberg HS, Sadzot B, Meltzer CC, et al. Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography. Ann Neurol 1991;30:3-11.
34. 18F]cyclofoxy. Epilepsy Res 1992;13:129-39.
35. 11C]diprenorpine activation study in patients with reading epilepsy. Epilepsia 1995;36(Suppl 3):S138.
36. Theodore WH, Leiderman D, Gaillard W, et al. The effect of naloxone on cerebral blood flow and glucose metabolism in patients with complex partial seizures. Epilepsy Res 1993;16:51-4.
37. 11C]diprenorphine and positron emission tomography. Epilepsy Res 1994;19:71-7.
38. Bartenstein PA, Duncan JS, Prevett MC, et al. Investigation of the opioid system in absence seizures with positron emission tomography. J Neurol Neurosurg Psychiatry 1993;56:1295-302.
39. Kasa P. The cholinergic systems in brain and spinal cord. Prog Neurobiol 1986;26:211-72.
40. Segal M. Acetylcholine and epilepsy. In: Fisher RS, Coyle JT, eds. Neurotransmitters and Epilepsy New York:Wiley-Liss 1991: 95-101.
41. Pennell PB, Burdette DE, Henry TR, Ross DA, Sackellares JC, Frey KA. Hippocampal muscarinic receptor binding in mesial temporal lobe epilepsy. Neurology 1994;44(Suppl 2):A176-7.
42. 11C]NMPB), a muscarinic acetylcholine receptor antagonist. Nucl Med Biol 1995;22:13-7.
43. Suhara T, Inoue O, Kobayashi K, Suzuki K, Tateno Y. Age-related changes in human muscarinic acetylcholine receptors measured by positron emission tomography. Neurosci Lett 1993; 149:225-8.
44. Pennell PB, Henry TR, Koeppe RA, Kilbourn MR, Frey KA. PET imaging of benzodiazepine and muscarinic receptor losses in mesial temporal lobe epilepsy. Epilepsia 1995;36(Suppl 4):24.
45. 3H]-PK 11195 binding sites in human epileptic hippocampus. Epilepsia 1992;33:610-7.
46. Fowler JS, Wang GJ, Logan J, et al. Selective reduction of radiotracer trapping by deuterium substitution: comparison of carbon-11-L-deprenyl and carbon-11-deprenyl-D2 for MAO B mapping. J Nucl Med 1995;36:1255-62.
47. 11C]deuterium-deprenyl in temporal lobe epilepsy. Epilepsia 1995;36:712-21.
48. Junck L, Olson JM, Ciliax BJ, et al. PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site. Ann Neurol 1989;26:752-8.
49. Groom GN, Junck L, Foster NL, Frey KA, Kuhl DE. PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease. J Nucl Med 1995;36:2207-10.
50. Mesulam M-M. Large-scale neurocognitive networks and distributed processing for attention, language, and memory. Ann Neurol 1990;28:597-613.
51. Mazziotta JC, Phelps ME. Human sensory stimulation and deprivation: positron emission tomographic results and strategies. Ann Neurol 1984;15(Suppl):S50-60.
52. Mazziotta JC, Huang S-C, Phelps ME, Carson RE, MacDonald NS, Mahoney K. A noninvasive positron computed tomography technique using oxygen-15-labeled water for the evaluation of neurobehavioral task batteries, J Cereb Blood Flow Metab 1985; 5:70-8.
53. Swartz BE, Halgren E, Fuster JM, Simpkins F, Gee M, Mandelkern M. Cortical metabolic activation in humans during a visual memory task. Cerebral Cortex 1995;3:205-14.
54. Swartz BE, Halgren E, Simpkins F, Syndulko K. Primary memory in patients with frontal and primary generalized epilepsy. J Epilepsy 1994;7:232-41.
55. 18FDG-PET study of dysfunctional zones. Neurology 1996a;46:(in press).
56. 18FDG-positron emission tomography in normal controls and subjects with epilepsy. Life Sci 1996b:(in press).
57. Novelly RA, Augustine EA, Mattson RH. Selective memory improvement and impairment in temporal lobectomy for epilepsy. Ann Neurol 1984;23:64-7.
58. Rausch R, Crandall PH. Psychological status related to surgical control of temporal lobe seizures. Epilepsia 1982;23:191-202.
59. Mazziotta JC, Phelps ME, Carson RE, Kuhl DE. Tomographic mapping of human cerebral metabolism: auditory stimulation. Neurology 1982;32:921-37.
60. Grasby PM, Frith CD, Friston KJ, Bench C, Frackowiak RSJ, Dolan RJ. Functional mapping of brain areas implicated in auditory-verbal memory function. Brain 1993;116:1-20.
61. Petersen SE, Fox, PT, Posner MI, Mintun MA, Raichle ME. Positron emission tomographic studies of the cortical anatomy of single-word processing. Nature 1988;331:585-9.
62. Petersen SE, Fox PT, Posner MI, Mintun MA, Raichle ME. Positron emission tomographic studies of the processing of single words. J Cognitive Neurosci 19891:153-70.
63. Petersen SE, Fox PT, Snyder AZ, Raichle ME. Activation of extrastriate-and frontal cortical areas by visual words and word-like stimuli. Science 1990;249:1041-4.
64. Wise R, Chollet F, Hadar U, Friston K, Hoffner E, Frackowiak R. Distribution of cortical neural networks involved in word comprehension and word retrieval. Brain 1991;114:1803-17.
65. Stafiniak P, Saykin AJ, Sperling MR. Acute naming deficits following dominant temporal lobectomy: prediction by age at 1st risk for seizures. Neurology 1990;40:1509-12.
66. Langfitt JT, Rausch R. Word-finding deficits persist after left anterotemporal lobectomy. Arch Neurol 1966;53:72-6.
67. Lüders H, Lesser RP, Hahn J. Basal temporal language area demonstrated by electrical stimulation. Neurology 1986;36:505-10.
68. Henry TR, Buchtel HA, Minoshima S, Koeppe RA. Regional cerebral blood flow increases during naming in left temporal lobe epilepsy. Neurology 1994c;44(Suppl 2):A351.
69. Maugière F, Kahane P, Grégoire MC. et al. PET study of cerebral blood flow changes during focal epileptic discharges induced by intracerebral electrical stimulation. Epilepsia 1995;36(Suppl 3):S212.
70. Engel J Jr, Kuhl DE, Phelps ME, Crandall PH. Comparative localization of epileptic foci in partial epilepsy by PCT and EEG. Ann Neurol 1982c;12:529-37.
71. Henry TR, Mazziotta JC, Engel J Jr. Interictal metabolic anatomy of mesial temporal lobe epilepsy. Arch Neurol 1993d;50:582-9.
72. Rubin E, Dhawan V, Moeller JR, et al. Cerebral metabolic topography in unilateral temporal lobe epilepsy. Neurology 1995; 45:2212-23.
73. Henry TR, Sutherling WW, Engel J Jr, et al. Interictal cerebral metabolism in partial epilepsies of neocortical origin. Epilepsy Res 1991;10:174-82.
74. Meyer JS, Hata T, Imai A. Clinical and experimental studies of diaschisis. In: Wood JH, ed. Cerebral Blood Flow New York:McGraw-Hill, 1987:481-502.
75. Engel J Jr, Brown WJ, Kuhl DE, Phelps ME, Mazziotta JC, Crandall PH. Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy. Ann Neurol 1982a;12: 518-28.
76. Henry TR, Babb TL, Engel J Jr, Mazziotta JC, Phelps ME, Crandall PH. Hippocampal neuronal loss and regional metabolism in temporal lobe epilepsy. Ann Neurol 1994b;36:925-7.
77. Sackellares JC, Siegel GJ, Abou-Khalil BW, et al. Differences between lateral and mesial temporal metabolism interictally in epilepsy of mesial temporal origin. Neurology 1990;40:1420-6.
78. Swartz BE, Tomiyasu U, Delgado-Escueta AV, Mandelkern M. Khonsari A. Neuroimaging in temporal lobe epilepsy: test sensitivity and relationships to pathology and post-surgical outcome. Epilepsia 1992;33:624-34.
79. Theodore WH, Holmes MD, Dorwart RH, et al. Complex partial seizures: cerebral structure and cerebral function, Epilepsia 1986; 27:576-82.
80. Gaillard WD, Bhatia S, Bookheimer SY, Fazilat S, Sato S, Theodore WH. FDG-PET and volumetric MRI in the evaluation of patients with partial epilepsy. Neurology 1995;45:123-6.
81. O'Brien TJ, Newton MR, Berlangieri S, et al. The magnitudes of FDG-PET temporal lobe asymmetry do not correlate with volumetric MRI hippocampal ratios in mesial temporal sclerosis. Epilepsia 1995;36(Suppl 4):166.
82. Semah F, Baulac M, Hasboun D, et al. Is interictal temporal hypometabolism related to mesial temporal sclerosis? a positron emission tomography/magnetic resonance imaging confrontation. Epilepsia 1995;36:447-56.
83. Frey KA. Positron emission tomography. In: Siegel GJ, Agranoff BW, Albers RW, Molinoff PB, eds. Basic neurochemistry: molecular, cellular, and medical aspects, 5th ed. New York: Raven Press, 1994;935-55.
84. Margerison JH, Corsellis J. Epilepsy and the temporal lobes. Brain 1966;89:499-530.
85. Sloviter RS. The functional organization of the hippocampal dentate gyrus and its relevance to the pathogenesis of temporal lobe epilepsy. Ann Neurol 1994;35:640-54.
86. Chugani HT, Shewmon DA, Khanna S, et al. Interictal and postictal focal hypermetabolism on positron emission tomography. Pediatr Neurol 1993;9:10-5.
87. Leiderman DB, Albert P, Balish M, Bromfield M, Theodore WH. The dynamics of metabolic change following seizures as measured by positron emission tomography with fluorodeoxyglucose F 18. Arch Neurol 1994;51:932-6.
88. Savic I, Altschuler L, Baxter L, Engel J Jr. Is the pattern of regional hypometabolism in partial epilepsy determined by the type of last seizure before the PET scan? Epilepsia 1995a;36 (Suppl 4):164.
89. Henry TR, Engel J Jr, Davis C, Phelps ME. Seizure recency and frequency effects on the probability of finding focal hypometabolism on interictal fluorodeoxyglucose PET scans in complex partial epilepsy. Epilepsia 1987;28:619.
90. Hajek M, Wieser H-G, Khan N, et al. Preoperative and postoperative glucose consumption in mesiobasal and lateral temporal lobe epilepsy. Neurology 1994;44:2125-32.
91. Salanova V, Morris HH, Rehm P, et al. Comparison of the intracarotid amobarbital procedure and interictal cerebral 18-fluorodeoxyglucose positron emission tomography scans in refractory temporal lobe epilepsy. Epilepsia 1992;33:635-8.
92. Rausch R, Henry TR, Ary CM, Engel J Jr, Mazziotta JC. Asymmetric interictal glucose hypometabolism and cognitive performance in epileptic patients. Arch Neurol 1994;51:139-44.
93. Victoroff JI, Benson F, Grafton ST, Engel J Jr, Mazziotta JC. Depression in complex partial seizures: electroencephalography and cerebral metabolic correlates. Arch Neurol 1994;51:155-63.
94. Bromfield EB, Alschuler L, Leiderman DB, et al. Cerebral metabolism and depression in patients with complex partial seizures. Arch Neurol 1992;49:617-23.
95. Hosokawa S, Kato M, Otsuka M, Kuwabawa Y, Ichiya Y, Goto I. Positron emission tomography in epilepsy: correlative study. Jpn J Psychiatr Neurol 1989;43:349-53.
96. Franceschi M, Lucignani G, Del Sole A, et al. Increased interictal cerebral glucose metabolism in a cortical-subcortical network in drug naive patients with cryptogenic temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 1995;59:427-31.
97. Chugani HT, Shields WD, Shewmon DA, Olson DM, Phelps ME, Peacock WJ. Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment. Ann Neurol 1990;24:406-13.
98. Chugani HT, Shewmon DA, Sankar R, Chen BC, Phelps ME. Infantile spasms: II. lenticular nuclei and brainstem activation on positron emission tomography. Ann Neurol 1992;31:212-9.
99. Chugani HT, Conti JR. Etiologic classification of infantile spasms in 140 cases: role of positron emission tomography. J Child Neurol 1996;11:44-8.
100. 18F]fluoro-D-glucose positron emission tomography. Ann Neurol 1987;21:4-13.
101. Theodore WH, Rose D, Patronas N, et al. Cerebral glucose me- tabolism in the Lennox-Gastaut syndrome. Ann Neurol 1987;21: 14-21.
102. Rintahaka PJ, Chugani HT, Messa C, Phelps ME. Hemimegalencephaly: evaluation with positron emission tomography. Pediatr Neurol 1993;9:21-8.
103. Maquet P, Hirsch E, Dive D, et al. Cerebral glucose utilization during sleep in Landau-Kleffner syndrome: a PET study. Epilepsia 1990;31:778-83.
104. Rintahaka PJ, Chugani HT, Sankar R. Landau-Kleffner syndrome with continuous spikes and waves during slow-wave sleep. J Child Neurol 1995;10:127-33.
105. Henry TR, Chugani HT, Abou-Khalil BW, Theodore WH, Swartz BE. Positron emission tomography in presurgical evaluation of epilepsy. In: Engel J Jr, ed. Surgical Treatment of the Epilepsies, 2nd ed., Raven Press: New York. 1993a:211-32.
106. Engel J Jr, Henry TR, Risinger MW, et al. Presurgical evaluation for partial epilepsy: Relative contributions of chronic depth electrode recordings versus FDG-PET and scalp-sphenoidal ictal EEG. Neurology 1990;40:1670-7.
107. Sperling MR, Alavi A, Reivich M, French JA, O'Connor MJ. False lateralization of temporal lobe epilepsy with FDG positron emission tomography. Epilepsia 1995;36:722-7.
108. Theodore WH, Sato S, Kufta C, Balish MB, Bromfield EB, Leiderman D. Temporal lobectomy for uncontrolled seizures: the role of positron emission tomography. Ann Neurol 1992;32:789-94.
109. Radtke RA, Hanson MW, Hoffman JM, et al. Positron emision tomography: comparison of clinical utility in temporal lobe and extratemporal epilepsy. J Epilepsy 1994;7:27-33.
110. Henry TR, Engel J Jr, Mazziotta JC. Clinical evaluation of interictal fluorine-18-fluorodeoxyglucose PET in partial epilepsy. J Nucl Med 1993b;34:1892-8.
111. Ryvlin P, Cinotti L, Froment JC, et al. Metabolic patterns associated with non-specific magnetic resonance imaging abnormalities in temporal lobe epilepsy. Brain 1991;114:2363-83.
112. Ho SS, Berkovic SF, Berlangieri SU, at al. Comparison of ictal SPECT and interictal PET in the presurgical evaluation of temporal lobe epilepsy. Ann Neurol 1995;37:738-45.
113. Henry TR, Epilepsy. In: Kelley RE (ed.). Functional Neuroimaging Futura Publishing: Armonk, NY. 1994a;367-94.
114. Henry TR, Ross DA, Schuh LA, Drury I. Neuroimaging and extracranial EEG in complex partial seizures of bilateral hippocampal origin. Epilepsia 1995;36(Suppl 3):S98.
115. Manno EM, Sperling MR, Ding X, et al. Predictors of outcome alter anterior temporal lobectomy: positron emission tomography. Neurology 1994;44:2331-6.
116. Engel J Jr, Kuhl DE, Phelps ME. Patterns of human local cerebral glucose metabolism during epileptic seizures. Science 1982b;218:64-6.
117. Chugani HT, Rintahaka PJ, Shewmon DA. Ictal patterns of cerebral glucose utilization in children with epilepsy. Epilepsia 1994b;35:813-22.
118. Hajek M, Antonini A, Leenders KL, Wieser H-G. Epilepsia partialis continua studied with PET. Epilepsy Res 1991;9:44-8.
119. Noachtar S, Ebner A, Witte O, Seitz R. Palatal tremor of cortical origin presenting as epilepsia partialis continua. Epilepsia 1995; 36:207-9.
120. Engel J Jr, Lubens P, Kuhl DE, Phelps ME. Local cerebral metabolic rate for glucose during petit mal absences. Ann Neurol 1985;17:121-8.
121. 2(15)O and PET. Neurology 1995a;45:1396-402.
122. 11C-labeled diphenylhydantoin positron emission tomography in humans. Neurology 1983;33:580-5.
123. Leiderman DB, Balish MB, Bromfield EB, Theodore WH. The effect of valproic acid on human cerebral glucose metabolism. Epilepsia 1991;32:417-22.
124. Theodore W. H. Antiepileptic drugs and cerebral glucose metabolism. Epilepsia 1988;29(Suppl 2):S48-55.